Have you ever felt pain in your hands that makes everyday tasks feel difficult or even impossible?
Simple actions like buttoning a shirt, opening a jar, or shaking someone’s hand can become painful and frustrating. For many people, this is not just a temporary problem. It may be a sign of a condition called hand osteoarthritis.
Osteoarthritis, often called OA, is one of the most common joint conditions. It happens when the protective tissue in the joints slowly wears down over time. This leads to pain, stiffness, and difficulty moving the affected joints. While OA can affect many parts of the body, it often appears in the hands, especially in the small joints of the fingers.
Hand osteoarthritis can have a big impact on daily life. People may struggle with basic activities, feel constant discomfort, and lose strength in their hands. Although it is more common as people get older, it does not only affect the elderly. Symptoms can begin earlier and gradually become worse over time.
In fact, studies show that by the age of 85, nearly half of all women and about one quarter of men will experience hand osteoarthritis. This makes it a widespread issue that affects millions of people around the world.
For many years, treating hand OA has been challenging. While some medications can reduce pain, they often do not provide long-lasting relief, and there are limited options specifically designed for this condition. This is why new research in this area is so important.
Researchers from Monash University and Alfred Health have been studying a possible new treatment that may help people with hand osteoarthritis. They have been testing a medication called methotrexate, which has been used in medicine for many decades.
Methotrexate has been widely used since the 1980s, mainly to treat rheumatoid arthritis. This is a different type of arthritis that involves inflammation and swelling in the joints. Because methotrexate can reduce inflammation, scientists wondered if it might also help people with hand osteoarthritis, especially those who have signs of joint inflammation.
The research team, led by Professor Flavia Cicuttini, conducted a study to test this idea. In the study, people with hand osteoarthritis were given a weekly dose of 20 milligrams of methotrexate. The treatment lasted for six months. Another group of participants received a placebo, which is a pill with no active medicine.
At the end of the study, the results showed clear differences between the two groups. People who took methotrexate reported less pain and stiffness in their hands compared to those who took the placebo. This suggests that the drug may help reduce symptoms in people with hand OA.
Another important finding was that the improvement did not happen all at once. Instead, the benefits gradually increased over time. This means that the drug may offer ongoing relief rather than just a short-term effect.
These findings are important because they offer new hope for people living with hand osteoarthritis. For many patients, the condition can feel limiting and frustrating, especially when it affects daily tasks and independence.
The research is especially meaningful for women, who are more likely to develop hand osteoarthritis, particularly around menopause. Hormonal changes may play a role, although more research is needed to fully understand this link.
Even though the results are promising, the researchers say that more work still needs to be done. They want to better understand how long methotrexate can be used safely, what the best dose is, and whether it can slow down the damage to the joints over time.
This study was published in The Lancet, one of the world’s leading medical journals. It highlights the growing interest in finding better treatments for osteoarthritis and improving the quality of life for people with chronic joint pain.
For people living with hand osteoarthritis, this research offers something very important: hope. It suggests that a medication that is already widely available and affordable may soon become a useful option for managing this difficult condition.
While methotrexate is not yet a standard treatment for hand osteoarthritis, the findings show that progress is being made. With more research, it may become part of future treatment plans, helping people regain comfort, movement, and control in their daily lives.
If you care about arthritis, please read studies about extra virgin olive oil for arthritis, and pomegranate: A natural treatment for rheumatoid arthritis.
For more information about arthritis, please see recent studies about how to live pain-free with arthritis, and results showing medical cannabis may help reduce arthritis pain, back pain.
Copyright © 2026 Knowridge Science Report. All rights reserved.
